Literature DB >> 23719298

CD40L expression permits CD8+ T cells to execute immunologic helper functions.

Marco Frentsch1, Regina Stark, Nadine Matzmohr, Sarah Meier, Sibel Durlanik, Axel R Schulz, Ulrik Stervbo, Karsten Jürchott, Friedemann Gebhardt, Guido Heine, Morgan A Reuter, Michael R Betts, Dirk Busch, Andreas Thiel.   

Abstract

CD8(+) T cells play an essential role in immunity against intracellular pathogens, with cytotoxicity being considered their major effector mechanism. However, we here demonstrate that a major part of central and effector memory CD8(+) T cells expresses CD40L, one key molecule for CD4(+) T-cell-mediated help. CD40L(+) CD8(+) T cells are detectable among human antigen-specific immune responses, including pathogens such as influenza and yellow fever virus. CD40L(+) CD8(+) T cells display potent helper functions in vitro and in vivo, such as activation of antigen-presenting cells, and exhibit a cytokine expression signature similar to CD4(+) T cells and unrelated to cytotoxic CD8(+) T cells. The broad occurrence of CD40L(+) CD8(+) T cells in cellular immunity implicates that helper functions are not only executed by major histocompatibility complex (MHC) class II-restricted CD4(+) helper T cells but are also a common feature of MHC class I-restricted CD8(+) T cell responses. Due to their versatile functional capacities, human CD40L(+) CD8(+) T cells are promising candidate cells for immune therapies, particularly when CD4(+) T-cell help or pathogen-associated molecular pattern signals are limited.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23719298      PMCID: PMC4548794          DOI: 10.1182/blood-2013-02-483586

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  39 in total

1.  Two subsets of memory T lymphocytes with distinct homing potentials and effector functions.

Authors:  F Sallusto; D Lenig; R Förster; M Lipp; A Lanzavecchia
Journal:  Nature       Date:  1999-10-14       Impact factor: 49.962

2.  Updated Epstein-Barr virus (EBV) DNA sequence and analysis of a promoter for the BART (CST, BARF0) RNAs of EBV.

Authors:  Orlando de Jesus; Paul R Smith; Lindsay C Spender; Claudio Elgueta Karstegl; Hans Helmut Niller; Dolly Huang; Paul J Farrell
Journal:  J Gen Virol       Date:  2003-06       Impact factor: 3.891

Review 3.  Cross-priming in health and disease.

Authors:  Christian Kurts; Bruce W S Robinson; Percy A Knolle
Journal:  Nat Rev Immunol       Date:  2010-06       Impact factor: 53.106

4.  CD40L co-stimulation from CD8+ to CD4+ effector memory T cells supports CD4+ expansion.

Authors:  Maria Xydia; Yingzi Ge; Ulrike Quitsch; Philipp Beckhove
Journal:  Immunol Cell Biol       Date:  2010-12-14       Impact factor: 5.126

Review 5.  CD4 T cells: fates, functions, and faults.

Authors:  Jinfang Zhu; William E Paul
Journal:  Blood       Date:  2008-09-01       Impact factor: 22.113

Review 6.  Immunological mechanisms of vaccination.

Authors:  Bali Pulendran; Rafi Ahmed
Journal:  Nat Immunol       Date:  2011-06       Impact factor: 25.606

7.  CD8 T cells specific for human immunodeficiency virus, Epstein-Barr virus, and cytomegalovirus lack molecules for homing to lymphoid sites of infection.

Authors:  G Chen; P Shankar; C Lange; H Valdez; P R Skolnik; L Wu; N Manjunath; J Lieberman
Journal:  Blood       Date:  2001-07-01       Impact factor: 22.113

8.  The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response.

Authors:  Rama S Akondy; Nathan D Monson; Joseph D Miller; Srilatha Edupuganti; Dirk Teuwen; Hong Wu; Farah Quyyumi; Seema Garg; John D Altman; Carlos Del Rio; Harry L Keyserling; Alexander Ploss; Charles M Rice; Walter A Orenstein; Mark J Mulligan; Rafi Ahmed
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

Review 9.  Phenotype and function of human T lymphocyte subsets: consensus and issues.

Authors:  Victor Appay; Rene A W van Lier; Federica Sallusto; Mario Roederer
Journal:  Cytometry A       Date:  2008-11       Impact factor: 4.355

10.  Anti-dsDNA-NcX ELISA: dsDNA-loaded nucleosomes improve diagnosis and monitoring of disease activity in systemic lupus erythematosus.

Authors:  Robert Biesen; Cornelia Dähnrich; Anke Rosemann; Fidan Barkhudarova; Thomas Rose; Olga Jakob; Anne Bruns; Marina Backhaus; Winfried Stöcker; Gerd-Rüdiger Burmester; Wolfgang Schlumberger; Karl Egerer; Falk Hiepe
Journal:  Arthritis Res Ther       Date:  2011-02-10       Impact factor: 5.156

View more
  30 in total

1.  Effects of aging on human leukocytes (part II): immunophenotyping of adaptive immune B and T cell subsets.

Authors:  Ulrik Stervbo; Cecilia Bozzetti; Udo Baron; Karsten Jürchott; Sarah Meier; Julia Nora Mälzer; Mikalai Nienen; Sven Olek; Dominika Rachwalik; Axel Ronald Schulz; Avidan Neumann; Nina Babel; Andreas Grützkau; Andreas Thiel
Journal:  Age (Dordr)       Date:  2015-09-02

2.  CD29 identifies IFN-γ-producing human CD8+ T cells with an increased cytotoxic potential.

Authors:  Benoît P Nicolet; Aurélie Guislain; Floris P J van Alphen; Raquel Gomez-Eerland; Ton N M Schumacher; Maartje van den Biggelaar; Monika C Wolkers
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-11       Impact factor: 11.205

Review 3.  Cancer immunotherapy: activating innate and adaptive immunity through CD40 agonists.

Authors:  Gregory L Beatty; Yan Li; Kristen B Long
Journal:  Expert Rev Anticancer Ther       Date:  2016-12-14       Impact factor: 4.512

4.  CD28 days later: Resurrecting costimulation for CD8(+) memory T cells.

Authors:  Verena van der Heide; Dirk Homann
Journal:  Eur J Immunol       Date:  2016-07       Impact factor: 5.532

5.  Enhancing antitumor efficacy of chimeric antigen receptor T cells through constitutive CD40L expression.

Authors:  Kevin J Curran; Beatrijs A Seinstra; Yan Nikhamin; Raymond Yeh; Yelena Usachenko; Dayenne G van Leeuwen; Terence Purdon; Hollie J Pegram; Renier J Brentjens
Journal:  Mol Ther       Date:  2015-01-13       Impact factor: 11.454

Review 6.  The immunoregulatory role of type I and type II NKT cells in cancer and other diseases.

Authors:  Masaki Terabe; Jay A Berzofsky
Journal:  Cancer Immunol Immunother       Date:  2014-01-03       Impact factor: 6.968

7.  T Cell Cancer Therapy Requires CD40-CD40L Activation of Tumor Necrosis Factor and Inducible Nitric-Oxide-Synthase-Producing Dendritic Cells.

Authors:  Ilaria Marigo; Serena Zilio; Giacomo Desantis; Bernhard Mlecnik; Andrielly H R Agnellini; Stefano Ugel; Maria Stella Sasso; Joseph E Qualls; Franz Kratochvill; Paola Zanovello; Barbara Molon; Carola H Ries; Valeria Runza; Sabine Hoves; Amélie M Bilocq; Gabriela Bindea; Emilia M C Mazza; Silvio Bicciato; Jérôme Galon; Peter J Murray; Vincenzo Bronte
Journal:  Cancer Cell       Date:  2016-09-12       Impact factor: 31.743

8.  The role of CD4(+) T cells in BKV-specific T cell immunity.

Authors:  B J D Weist; M Schmueck; H Fuehrer; A Sattler; P Reinke; N Babel
Journal:  Med Microbiol Immunol       Date:  2014-07-23       Impact factor: 3.402

Review 9.  What Happens in the Thymus Does Not Stay in the Thymus: How T Cells Recycle the CD4+-CD8+ Lineage Commitment Transcriptional Circuitry To Control Their Function.

Authors:  Melanie S Vacchio; Rémy Bosselut
Journal:  J Immunol       Date:  2016-06-15       Impact factor: 5.422

10.  Cancer immunotherapy using a potent immunodominant CTL epitope.

Authors:  Liwen Song; Ming-Chieh Yang; Jayne Knoff; Zu-Yue Sun; T-C Wu; Chien-Fu Hung
Journal:  Vaccine       Date:  2014-09-20       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.